QL1706H
/ Qilu Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
September 21, 2023
A Study of QL1706H in Patients With Advanced Solid Tumors
(clinicaltrials.gov)
- P1 | N=150 | Not yet recruiting | Sponsor: Qilu Pharmaceutical Co., Ltd.
Metastases • New P1 trial • Oncology • Solid Tumor
1 to 1
Of
1
Go to page
1